Literature DB >> 17804903

Nonhematological benefits of iron.

Rajiv Agarwal1.   

Abstract

Iron deficiency anemia is common in people with chronic kidney disease (CKD) and its importance in supporting erythropoiesis is unquestioned especially in those patients treated with erythropoietin. Clinical symptomatology such as fatigability, cold intolerance, failure to concentrate and poor effort intolerance is often attributed to anemia or uremia. That iron deficiency, per se, can cause these symptoms is poorly recognized. Clinical and animal studies that support the benefits of iron supplementation, independent of increasing hemoglobin, such as those on immune function, physical performance, thermoregulation, cognition, and restless leg syndrome and aluminum absorption is the subject of this narrative review. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804903     DOI: 10.1159/000107927

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  19 in total

Review 1.  The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review.

Authors:  Dylan L Petkus; Laura E Murray-Kolb; Mary Jane De Souza
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

2.  Serum iron and iron stores in non-anemic patients with fibromyalgia.

Authors:  Reuven Mader; Yael Koton; Dan Buskila; Paula Herer; Mazen Elias
Journal:  Clin Rheumatol       Date:  2011-11-19       Impact factor: 2.980

3.  Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.

Authors:  Hassan N Ibrahim; Robert N Foley; Rui Zhang; David T Gilbertson; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

4.  Transferrin saturation and hospital length of stay and mortality in Medicare beneficiaries.

Authors:  Arch G Mainous; Vanessa A Diaz; Michele E Knoll; Mary M Hulihan; Althea M Grant; Robert U Wright
Journal:  J Am Geriatr Soc       Date:  2012-12-03       Impact factor: 5.562

5.  Iron, oxidative stress, and clinical outcomes.

Authors:  Rajiv Agarwal
Journal:  Pediatr Nephrol       Date:  2007-11-21       Impact factor: 3.714

Review 6.  Safety issues with intravenous iron products in the management of anemia in chronic kidney disease.

Authors:  Amir Hayat
Journal:  Clin Med Res       Date:  2008-12

Review 7.  When less is more: novel mechanisms of iron conservation.

Authors:  Marina Bayeva; Hsiang-Chun Chang; Rongxue Wu; Hossein Ardehali
Journal:  Trends Endocrinol Metab       Date:  2013-08-12       Impact factor: 12.015

8.  Effects of iron supplementation on erythropoietic response in patients with cancer-associated anemia treated by means of erythropoietic stimulating agents.

Authors:  Torbjörn Karlsson
Journal:  ISRN Hematol       Date:  2011-10-13

9.  The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency.

Authors:  Cem Çekiç; Serkan İpek; Fatih Aslan; Zehra Akpınar; Mahmut Arabul; Firdevs Topal; Elif Sarıtaş Yüksel; Emrah Alper; Belkıs Ünsal
Journal:  Gastroenterol Res Pract       Date:  2015-01-26       Impact factor: 2.260

10.  Transferrin saturation ratio and risk of total and cardiovascular mortality in the general population.

Authors:  A G Stack; A I Mutwali; H T Nguyen; C J Cronin; L F Casserly; J Ferguson
Journal:  QJM       Date:  2014-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.